An extracellular polysaccharide was purified from culture supernatants of Paenibacillus jamilae CP-7, a gram-positive bacillus that was isolated from compost prepared with olive mill wastewaters. The extracellular polysaccharide was produced under aerobic conditions in a medium containing olive mill wastewaters (80% [vol/vol]). This exopolymer had a low level of acute toxicity when it is administered to BALB/c mice by the intraperitoneal route. Interesting immunomodulatory effects were detected when mice were given 10 mg of exopolysaccharide per kg of body weight; the proliferative responses of splenocytes to B-cell and T-cell mitogens were suppressed, the in vitro levels of production of gamma interferon and granulocyte-macrophage colony-stimulating factor by unstimulated and lipopolysaccharide-stimulated splenocytes were enhanced, and the levels of resistance to the intracellular pathogen Listeria monocytogenes was increased in mice. Also, the exopolysaccharide was able to induce lymphocyte proliferation in vitro. We conclude that P. jamilae produces an exopolysaccharide with interesting immunomodulatory properties.Microbial exopolysaccharides (EPSs) often show clearly identified properties that form the basis for a wide range of applications in food, pharmaceutical, petroleum, and other industries (32). Thus, several EPSs have been shown to possess immunological activities with potential pharmacological applications as biological response modifiers (BRMs). BRMs are agents that alter the normal immune response and whose mechanisms of action include induction of cytokines (29). Research on pharmacological applications of BRMs has led to development of both immunosuppressive and immunostimulating drugs that are effective in preventing the rejection of transplanted organs, for the treatment of some autoimmune diseases, as cancer immunotherapy, or as adjuvants for vaccine construction (14). Lentinan and other fungal glucans, yeast mannan fractions, and a number of bacterial EPSs have been identified as BRMs and have been found to have the ability to stimulate tumor rejection (for a review, see reference 40). In recent years, research has focused on the mechanisms of action of these compounds (12, 41), as well as on the discovery of new ones (7,33).Although polysaccharides are considered to be T-cell-independent antigens, a number of microbial EPSs are immunomodulators, with activities for T cells and macrophages (for a review, see reference 35). Polysaccharide A, a component of the capsular complex of Bacteroides fragilis, possesses mitogenic activity for T lymphocytes (6), and the production of interleukin-2 (IL-2) by CD4ϩ T cells appears to play an essential role in the in vivo immunomodulation by this EPS (37). A number of fungi and yeasts produce -(1,3)-glucans with immunomodulatory properties (4, 35). Studies on the mechanisms of immunomodulation by a soluble derivative of -(1,3)-glucan have shown that it has the ability to prime granulocytes and macrophages for enhanced cytokine release (30), reactive nitr...